HomeInsights52 Week High Stocks

Glaxosmithkline Pharmaceuticals Ltd 52 Week High

Glaxosmithkline Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.3 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 28, 2024

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

YEARHIGH

₹ 3087.95

Last updated on: Dec 27, 2024

Key Highlights

  • The 52 Week HIGH of Glaxosmithkline Pharmaceuticals Ltd is ₹ 3087 as of 27 Dec 24 .

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

No data available

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20242271.05
26 Dec 20242241.8
24 Dec 20242265.1
23 Dec 20242282.85
20 Dec 20242284.5
19 Dec 20242325.25
18 Dec 20242334.95
17 Dec 20242264.65
16 Dec 20242278.95
13 Dec 20242254.45

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 2024 10:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 2024 16:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 2024 10:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 2024 12:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 2024 10:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 2024 13:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Glaxosmithkline Pharmaceuticals Ltd

What is the significance of Glaxosmithkline Pharmaceuticals Ltd reaching its 52-week high?

Glaxosmithkline Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Glaxosmithkline Pharmaceuticals Ltd 52-week high?

Investors monitor Glaxosmithkline Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Glaxosmithkline Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Glaxosmithkline Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Glaxosmithkline Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Glaxosmithkline Pharmaceuticals Ltd at its 52-week high?

Before investing in Glaxosmithkline Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Glaxosmithkline Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Glaxosmithkline Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions